NDC 68135-100 – Vimizim

Elosulfase Alfa 5 mg/5mL · Injection, Solution, Concentrate · Intravenous

Human Prescription Drug

Product NDC68135-100

Product details

Brand name
Vimizim
Generic name
Elosulfase alfa
Labeler
BioMarin Pharmaceutical Inc.
Dosage form
Injection, Solution, Concentrate
Route
Intravenous
Marketing category
BLA · BLA125460
Marketed since
February 14, 2014
Listing expires
December 31, 2026
Pharmacologic class
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme

Active ingredients

Uses, dosage, side effects and warnings for Vimizim →

Package NDC codes (1)

Package NDCDescriptionSince
68135-100-011 VIAL in 1 CARTON (68135-100-01) / 5 mL in 1 VIALFeb 14, 2014